GSK3A and schizophrenia: This mouse line displayed a variety of schizophrenia-related abnormalities including hyperlocomotion, impaired pre-pulse inhibition/latent inhibition, deficient neurogenesis/neuron migration, enhanced dopamine function and dendritic spine deficits rescued by genetic inactivation of GSK3α [26, 29, 30].